Immanuel Thangaraj - Jan 3, 2023 Form 4 Insider Report for ACURA PHARMACEUTICALS, INC (ACUR)

Role
Director
Signature
/s/ Immanuel Thangaraj
Stock symbol
ACUR
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 03:06 PM
Previous filing
Jan 12, 2022
Next filing
Jan 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACUR Common Stock Options Exercise +66.7K +20.14% 398K Jan 3, 2023 Direct F1, F2, F3
holding ACUR Common Stock 1.96M Jan 3, 2023 By Essex Woodlands Health Venture Fund V, L.P. F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACUR Restricted Stock Units (2021 Plan) Options Exercise -66.7K -100% 0 Jan 3, 2023 Common Stock 66.7K Direct F2, F4, F5, F6
transaction ACUR Restricted Stock Units (2021 Plan) Award -50K -50% 50K Jan 3, 2023 Common Stock 50K Direct F2, F4, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents exchange of restricted stock units.
F2 Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
F3 Does not include Restricted Stock Units.
F4 1 - for - 1
F5 66,666 Restricted Stock Units were granted on January 3, 2022. 25% of Restricted Stock Units vested on the last day of each of March, June, September and December 2022. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
F6 N/A
F7 50,000 Restricted Stock Units were granted on January 3, 2023. 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2023, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2024, or earlier upon a change of control.
F8 The reporting person is a managing director of the general partner of Essex Woodlands Health Ventures Fund V, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.